Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 26, Issue 6, Pages 293-296
http://dx.doi.org/10.1155/2015/974871
Letter to the Editor

Treatment Outcomes with Telaprevir-Based Therapy for HIV/Hepatitis C Coinfected Patients are Comparable with Hepatitis C Monoinfected Patients

Conar R O’Neil,1 Jack XQ Pang,2 Samuel S Lee,2 Mark G Swain,2 Kelly W Burak,2 Patricia Klein,2 Robert P Myers,2 Jeff Kapler,3 Michael J Gill,4 Martin Labrie,5 and Carla S Coffin2,4

1Department of Internal Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada
2Calgary Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada
3Southern Alberta Clinic, Calgary, Alberta, Canada
4Southern Alberta Clinic, Department of Microbiology, Immunology and Infectious Diseases, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada
5Southern Alberta Clinic, Department of Family Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada

Copyright © 2015 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Conar R O’Neil, Jack XQ Pang, Samuel S Lee, et al., “Treatment Outcomes with Telaprevir-Based Therapy for HIV/Hepatitis C Coinfected Patients are Comparable with Hepatitis C Monoinfected Patients,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 26, no. 6, pp. 293-296, 2015. https://doi.org/10.1155/2015/974871.